Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial.
- 2021-11-19
- RCT · n = 110
- BMC complementary medicine and therapies 21(1)
- Kourosh Masnadi Shirazi
- Elham Shirinpour
- Arman Masnadi Shirazi
- Zeinab Nikniaz
- PubMed: 34798892
- DOI: 10.1186/s12906-021-03436-6
- High evidence
- Large Human Trial
- Clinical
Significantly more patients in the cranberry group experienced a decrease in steatosis level compared with the control group.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 144 mg/day